![Thomas Hennessey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas V. Hennessey est membre du conseil d'administration d'AutoGenomics, Inc. Dans le passé, il a été directeur de l'exploitation et des finances d'AutoImmune, directeur de l'exploitation et des finances de Boston Scientific Corp, directeur de l'exploitation et des finances de Cambridge Heart, directeur des finances de LumeRx, directeur de l'exploitation et des finances de Photovac, directeur de l'exploitation et des finances de Behring Diagnostics Business, directeur de l'exploitation et des finances de PHT Corp, directeur de l'exploitation et des finances de Medical Diagnostics, Inc. et directeur de l'exploitation et des finances de SonaMed Corp. Thomas V. Hennessey est titulaire d'un diplôme d'études supérieures et d'un diplôme de premier cycle du Massachusetts Institute of Technology et d'un MBA de la Harvard Business School.
| Sociétés | Poste | Début |
|---|---|---|
Hopewell Therapeutics, Inc.
 Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Develops novel synthetic lipid based nanoparticles for nucleic acid delivery for gene therapy & gene editing | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Photovac, Inc.
 Photovac, Inc. Medical SpecialtiesHealth Technology Portable environmental instruments | Directeur Financier/CFO | 01/01/2003 |
PHT Corp.
 PHT Corp. Packaged SoftwareTechnology Services Designs and develops software applications | Directeur Financier/CFO | - |
| CAMBRIDGE HEART, INC. | Directeur Financier/CFO | - |
AutoGenomics, Inc.
 AutoGenomics, Inc. Medical SpecialtiesHealth Technology Designs and develops molecular diagnostics system | Directeur Financier/CFO | 31/08/2013 |
SonaMed Corp.
 SonaMed Corp. Medical SpecialtiesHealth Technology Designs and develops medical devices | Directeur Financier/CFO | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 13 |
|---|---|
AutoImmune, Inc.
 AutoImmune, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals orally administered | Health Technology |
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Cambridge Heart, Inc.
 Cambridge Heart, Inc. Medical SpecialtiesHealth Technology Engages in research, development and commercialization of products for the non-invasive diagnosis of cardiac disease | Health Technology |
LumeRx, Inc.
 LumeRx, Inc. Medical SpecialtiesHealth Technology Develops radiation technology that eliminates bacteria | Health Technology |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology Designs and develops molecular diagnostics system | Health Technology |
Medical Diagnostics, Inc.
 Medical Diagnostics, Inc. Medical/Nursing ServicesHealth Services Mobile MRI services | Health Services |
PHT Corp.
PHT Corp. Packaged SoftwareTechnology Services Designs and develops software applications | Technology Services |
Behring Diagnostics Business
 Behring Diagnostics Business Medical SpecialtiesHealth Technology Provides diagnostic services | Health Technology |
Photovac, Inc.
Photovac, Inc. Medical SpecialtiesHealth Technology Portable environmental instruments | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
SonaMed Corp.
SonaMed Corp. Medical SpecialtiesHealth Technology Designs and develops medical devices | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hopewell Therapeutics, Inc.
Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Develops novel synthetic lipid based nanoparticles for nucleic acid delivery for gene therapy & gene editing | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
